Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.

Item
http://www.wikidata.org/entity/Q37683122
Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® VaccineNaturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.Rare subtype(s) and frequency of multi-viral subtype high-risk human papilloma virus infection in high-grade squamous intraepithelial lesion and squamous cell carcinoma in a cervical carcinoma prevalent developing country: a multiplex real-time polyProphylactic HPV vaccination: past, present, and future.Pre-clinical and clinical development of the first placental malaria vaccine.The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review.Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.The M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune
P2860

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.

Item
http://www.wikidata.org/entity/Q37683122
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@en
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@nl
type
label
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@en
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@nl
prefLabel
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@en
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Cross-protective vaccine effic ...... the Costa Rica Vaccine Trial.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932